Therapy news | Serendeputy: Newsfeed Engine for the open web

CALQUENCE® (acalabrutinib) Granted US Breakthrough Therapy Designation for Chronic Lymphocytic Leukemia
finance.yahoo.com | 2 hours ago | Article Details | Related Articles | Share
- 381 Tags
- 1 Tweet
Wedbush - Acer Therapeutics (ACER) ... The Week Ahead in Life Sciences
researchpool.com | 13 hours ago | Article Details | Related Articles | Share
- 469 Tags
- 1 Tweet
Nabriva Therapeutics Provides Update on the Planned Resubmission of the New Drug Application for Intravenous CONTEPO™ (fosfomycin) for Injection
crweworld.com | 20 hours ago | Article Details | Related Articles | Share
- 323 Tags
Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia
oncologytube.com | 14 hours ago | Article Details | Related Articles | Share
Better Therapies For TB Are Here, But They Will Not Deliver Themselves
forbes.com | 2 days ago | Article Details | Related Articles | Share
Plus Therapeutics Reports Q2 2019 Financial and Business Results
sectorpublishingintelligence.co.uk | 1 day ago | Article Details | Related Articles | Share
- 257 Tags
- 1 Tweet
VistaGen Therapeutics Achieves Target Patient Enrollment in the ELEVATE Study of AV-101 as an Adjunctive Treatment for Major Depressive Disorder
crweworld.com | 1 day ago | Article Details | Related Articles | Share
- 356 Tags
Arcturus Therapeutics Announces Second Quarter Financial Results and Provides a Corporate Update
crweworld.com | 1 day ago | Article Details | Related Articles | Share
- 406 Tags
Mirati Therapeutics Appoints Jenny Gizzi As Vice President, Human Resources
crweworld.com | 1 day ago | Article Details | Related Articles | Share
- 289 Tags
Plus Therapeutics Reports Q2 2019 Financial and Business Results
crweworld.com | 1 day ago | Article Details | Related Articles | Share
- 269 Tags
Marker Therapeutics Appoints Nadia Agopyan, Ph.D., RAC as Vice President of Regulatory Affairs
crweworld.com | 1 day ago | Article Details | Related Articles | Share
- 289 Tags
Calliditas Therapeutics: Interim Report Q2, 2019
prnewswire.com | 1 day ago | Article Details | Related Articles | Share
- 260 Tags
- 1 Tweet
AgeX Therapeutics, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update
businesswire.com | 2 days ago | Article Details | Related Articles | Share
- 485 Tags
- 3 Tweets
Wedbush - Aimmune Therapeutics (AIMT) ... 2019 Wedbush PacGrow Healthcare Conference: Day 1 Recap
researchpool.com | 2 days ago | Article Details | Related Articles | Share
- 462 Tags
- 1 Tweet
Wedbush - Acer Therapeutics (ACER) ... 2019 Wedbush PacGrow Healthcare Conference: Day 2 Recap
researchpool.com | 2 days ago | Article Details | Related Articles | Share
- 473 Tags
- 1 Tweet
FDA Approves First Therapy for Rare Joint Tumor : Oncology Times
journals.lww.com | 2 days ago | Article Details | Related Articles | Share
AstronauTx secures £6.5 million investment for new approach to dementia therapeutics
pharmiweb.com | 2 days ago | Article Details | Related Articles | Share
Windtree Therapeutics Reports Second Quarter 2019 Financial Results and Provides Key Business Updates
crweworld.com | 2 days ago | Article Details | Related Articles | Share
- 412 Tags
Stoke Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update
crweworld.com | 2 days ago | Article Details | Related Articles | Share
- 414 Tags
Akari Therapeutics Receives FDA Fast Track Designation for Nomacopan for Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)
crweworld.com | 2 days ago | Article Details | Related Articles | Share
- 377 Tags
NeuBase Therapeutics Reports Financial Results for the Fiscal Third Quarter of 2019
crweworld.com | 2 days ago | Article Details | Related Articles | Share
- 352 Tags
AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio
pharmiweb.com | 2 days ago | Article Details | Related Articles | Share
Fate Therapeutics Announces Issuance of Foundational U.S. Patent Covering iPSC-derived CAR T Cells
crweworld.com | 2 days ago | Article Details | Related Articles | Share
- 375 Tags
Outlook Therapeutics Provides Business Update and Reports Financial Results for Third Quarter of Fiscal 2019
crweworld.com | 2 days ago | Article Details | Related Articles | Share
- 371 Tags
Arcturus Therapeutics Announces Second Quarter Financial Results and Provides a Corporate Update
finance.yahoo.com | 2 days ago | Article Details | Related Articles | Share
AgeX Therapeutics, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update
crweworld.com | 2 days ago | Article Details | Related Articles | Share
- 482 Tags
Phio Pharmaceuticals and Helmholtz Zentrum München to Collaborate on Novel Targets for the Use of Self-Delivering RNAi In T Cell and NK Cell Adoptive Cell Therapy Therapeutics
crweworld.com | 2 days ago | Article Details | Related Articles | Share
- 235 Tags
CALQUENCE® (acalabrutinib) Granted US Breakthrough Therapy Designation for Chronic Lymphocytic Leukemia
crweworld.com | 2 days ago | Article Details | Related Articles | Share
- 391 Tags
FDA approves first therapy for rare joint tumor
worldpharmanews.com | 13 days ago | Article Details | Related Articles | Share
Bayer acquires BlueRock Therapeutics to build leading position in cell therapy
worldpharmanews.com | 7 days ago | Article Details | Related Articles | Share
Digital Therapeutics Hot Summer With Major IPOs and First Oncology App
forbes.com | 4 days ago | Article Details | Related Articles | Share
Protagonist Therapeutics Reports Second Quarter 2019 Financial Results
prnewswire.com | 4 days ago | Article Details | Related Articles | Share
Neuropore Therapies and BenevolentAI Enter Strategic Collaboration to Discover Novel Therapeutics Through the Application of Artificial Intelligence
businesswire.com | 11 days ago | Article Details | Related Articles | Share
A Professional Standard for Informed Consent for Stem Cell Therapies
jamanetwork.com | 4 days ago | Article Details | Related Articles | Share
FDA approves first therapy for rare joint tumor
fda.gov | 14 days ago | Article Details | Related Articles | Share
Enabling technologies in cell/gene therapy
medium.com | 10 days ago | Article Details | Related Articles | Share
Top 5 Emerging Therapeutics for Crigler – Najjar Syndrome | Avise Analytics
aviseanalytics.com | 9 days ago | Article Details | Related Articles | Share
- 500 Tags
- 2 Tweets
Wuhan Announces Strategic Reorganization for Its Operational Advancement in the Medical Marijuana and Psilocybin Mushroom Therapy Markets - NASDAQ.com
nasdaq.com | 9 days ago | Article Details | Related Articles | Share
- 355 Tags
- 6 Tweets
Vista Partners | San Diego-based FATE Therapeutics Reports Results for Q2
vistapglobal.com | 3 days ago | Article Details | Related Articles | Share
- 389 Tags
- 3 Tweets
Stemline Therapeutics Announces that CMS Grants New Technology Add-on Payment (NTAP) to ELZONRIS® Nasdaq:STML
nexbietv.ooo | 10 days ago | Article Details | Related Articles | Share
- 382 Tags
- 2 Tweets
Press Release: Unum Therapeutics Announces New Appointments to its Board of Directors 📰
robinspost.com | 19 days ago | Article Details | Related Articles | Share
Bayer acquires BlueRock Therapeutics to build leading position in cell therapy
prnewswire.com | 9 days ago | Article Details | Related Articles | Share
Audentes Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
pharmiweb.com | 10 days ago | Article Details | Related Articles | Share
5 Promising Companies to watch out for in the Batten Disease Therapeutic Market | Avise Analytics
aviseanalytics.com | 9 days ago | Article Details | Related Articles | Share
- 488 Tags
- 1 Tweet
Therapeutic Effects of Cannabis and Cannabinoids - The Health Effects of Cannabis and Cannabinoids - NCBI Bookshelf
ncbi.nlm.nih.gov | 14 days ago | Article Details | Related Articles | Share
Onconova Therapeutics, Inc. Reports Business Highlights and Second Quarter 2019 Financial Results
sectorpublishingintelligence.co.uk | 3 days ago | Article Details | Related Articles | Share
- 464 Tags
- 1 Tweet
BioXcel Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update
sectorpublishingintelligence.co.uk | 11 days ago | Article Details | Related Articles | Share
- 437 Tags
- 1 Tweet
Canopy Growth Strengthens Position as Global Cannabis Research Leader by Entering Agreement to Acquire Beckley Canopy Therapeutics
finance.yahoo.com | 8 days ago | Article Details | Related Articles | Share
- 364 Tags
- 1 Tweet
Canopy Growth Strengthens Position as Global Cannabis Research Leader by Entering Agreement to Acquire Beckley Canopy Therapeutics
prnewswire.com | 7 days ago | Article Details | Related Articles | Share
PTC Therapeutics Reports Second Quarter 2019 Financial Results and Provides a Corporate Update
pharmiweb.com | 10 days ago | Article Details | Related Articles | Share

Newsfeed engine for the open web

Therapy

CALQUENCE® (acalabrutinib) Granted US Breakthrough Therapy Designation for Chronic Lymphocytic Leukemia

Wedbush - Acer Therapeutics (ACER) ... The Week Ahead in Life Sciences

Nabriva Therapeutics Provides Update on the Planned Resubmission of the New Drug Application for Intravenous CONTEPO™ (fosfomycin) for Injection

Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia

Better Therapies For TB Are Here, But They Will Not Deliver Themselves

Plus Therapeutics Reports Q2 2019 Financial and Business Results

VistaGen Therapeutics Achieves Target Patient Enrollment in the ELEVATE Study of AV-101 as an Adjunctive Treatment for Major Depressive Disorder

Arcturus Therapeutics Announces Second Quarter Financial Results and Provides a Corporate Update

Mirati Therapeutics Appoints Jenny Gizzi As Vice President, Human Resources

Plus Therapeutics Reports Q2 2019 Financial and Business Results

Marker Therapeutics Appoints Nadia Agopyan, Ph.D., RAC as Vice President of Regulatory Affairs

Calliditas Therapeutics: Interim Report Q2, 2019

AgeX Therapeutics, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update

Wedbush - Aimmune Therapeutics (AIMT) ... 2019 Wedbush PacGrow Healthcare Conference: Day 1 Recap

Wedbush - Acer Therapeutics (ACER) ... 2019 Wedbush PacGrow Healthcare Conference: Day 2 Recap

FDA Approves First Therapy for Rare Joint Tumor : Oncology Times

AstronauTx secures £6.5 million investment for new approach to dementia therapeutics

Windtree Therapeutics Reports Second Quarter 2019 Financial Results and Provides Key Business Updates

Stoke Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update

Akari Therapeutics Receives FDA Fast Track Designation for Nomacopan for Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)

NeuBase Therapeutics Reports Financial Results for the Fiscal Third Quarter of 2019

AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio

Fate Therapeutics Announces Issuance of Foundational U.S. Patent Covering iPSC-derived CAR T Cells

Outlook Therapeutics Provides Business Update and Reports Financial Results for Third Quarter of Fiscal 2019

Arcturus Therapeutics Announces Second Quarter Financial Results and Provides a Corporate Update

AgeX Therapeutics, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update

Phio Pharmaceuticals and Helmholtz Zentrum München to Collaborate on Novel Targets for the Use of Self-Delivering RNAi In T Cell and NK Cell Adoptive Cell Therapy Therapeutics

CALQUENCE® (acalabrutinib) Granted US Breakthrough Therapy Designation for Chronic Lymphocytic Leukemia

FDA approves first therapy for rare joint tumor

Bayer acquires BlueRock Therapeutics to build leading position in cell therapy

Digital Therapeutics Hot Summer With Major IPOs and First Oncology App

Protagonist Therapeutics Reports Second Quarter 2019 Financial Results

Neuropore Therapies and BenevolentAI Enter Strategic Collaboration to Discover Novel Therapeutics Through the Application of Artificial Intelligence

A Professional Standard for Informed Consent for Stem Cell Therapies

FDA approves first therapy for rare joint tumor

Enabling technologies in cell/gene therapy

Top 5 Emerging Therapeutics for Crigler – Najjar Syndrome | Avise Analytics

Wuhan Announces Strategic Reorganization for Its Operational Advancement in the Medical Marijuana and Psilocybin Mushroom Therapy Markets - NASDAQ.com

Vista Partners | San Diego-based FATE Therapeutics Reports Results for Q2

Stemline Therapeutics Announces that CMS Grants New Technology Add-on Payment (NTAP) to ELZONRIS® Nasdaq:STML

Press Release: Unum Therapeutics Announces New Appointments to its Board of Directors 📰

Bayer acquires BlueRock Therapeutics to build leading position in cell therapy

Audentes Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

5 Promising Companies to watch out for in the Batten Disease Therapeutic Market | Avise Analytics

Therapeutic Effects of Cannabis and Cannabinoids - The Health Effects of Cannabis and Cannabinoids - NCBI Bookshelf

Onconova Therapeutics, Inc. Reports Business Highlights and Second Quarter 2019 Financial Results

BioXcel Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update

Canopy Growth Strengthens Position as Global Cannabis Research Leader by Entering Agreement to Acquire Beckley Canopy Therapeutics

Canopy Growth Strengthens Position as Global Cannabis Research Leader by Entering Agreement to Acquire Beckley Canopy Therapeutics

PTC Therapeutics Reports Second Quarter 2019 Financial Results and Provides a Corporate Update